Uptravi (selexipag)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Uptravi (selexipag), covering 2026-02-13 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Patient-Reported Outcomes and Adherence After Transition From Inhaled Iloprost to Oral Selexipag in Pulmonary Arterial Hypertension